{"id":4372,"date":"2026-10-12T08:33:02","date_gmt":"2026-10-12T08:33:02","guid":{"rendered":"https:\/\/nhdbio.com\/?p=4372"},"modified":"2026-10-12T08:33:02","modified_gmt":"2026-10-12T08:33:02","slug":"ss31-preuves-in-vitro-du-vieillissement-des-ovocytes","status":"publish","type":"post","link":"https:\/\/nhdbio.com\/fr\/ss31-oocyte-aging-invitro-evidence\/","title":{"rendered":"SS-31 et maturation des ovocytes : qu'a r\u00e9ellement test\u00e9 l'\u00e9tude d'octobre ?"},"content":{"rendered":"
\n
\"Illustration
Editorial illustration, not an experimental photograph.<\/figcaption><\/figure>\n

Oocyte maturation is not only a change in the nucleus; the inside of the cell also needs to prepare for later development. The SS-31 paper published on October 2 looked at both of these at the same time, and included in vitro experiments with mouse and human cells.<\/p>\n

\n

Maturation can be divided into two kinds of preparation<\/h2>\n

One is that the chromosomes in the nucleus must line up and separate in an orderly way; the other is that the energy supply, internal structures and material stores in the cytoplasm must be ready. The study calls these nuclear maturation and cytoplasmic maturation.<\/p>\n

You can think of it as two checklists before setting off: the route is arranged, and the car's energy and equipment also need to work. Confirming only one of these cannot guarantee that the later process will go smoothly.<\/p>\n<\/section>\n

\n

The mouse experiments looked at cell and reproductive outcomes<\/h2>\n

The study compared older and younger mice and observed oocyte structure, mitochondrial state and related metabolic changes. After SS-31 treatment, the paper reported improvements in cell quality and mouse reproductive performance.[1]<\/a><\/p>\n

The duration, ages and treatment conditions in the mouse experiments were all specifically designed. An improvement at one stage should not be written as permanently reversing the entire age-related change of the ovary.<\/p>\n<\/section>\n

\n

It also used human oocytes, but this was an in vitro study<\/h2>\n

The study placed obtained immature human oocytes in culture conditions, compared maturation, fertilization and early cleavage outcomes with and without SS-31, and reported related improvements.[1]<\/a><\/p>\n

The key point here is "in vitro": the treatment occurred in a culture system, and the studied embryos were not used for clinical transfer. Therefore, it cannot be said that giving women SS-31 increased pregnancy rates or live birth rates.<\/p>\n